Search the MBS

Standard Search

Advanced Search Search Tips

Enter keywords or item numbers below
Search Options

Results 1 to 1 of 1 matches

Category 2 - DIAGNOSTIC PROCEDURES AND INVESTIGATIONS

12201

12201 - Additional Information

Item Start Date:
01-May-2004
Description Start Date:
01-May-2004
Schedule Fee Start Date:
01-Nov-2012

Group
D1 - MISCELLANEOUS DIAGNOSTIC PROCEDURES AND INVESTIGATIONS
Subgroup
10 - OTHER DIAGNOSTIC PROCEDURES AND INVESTIGATIONS

Administration, by a specialist or consultant physician in the practice of his or her specialty, of thyrotropin alfa-rch (recombinant human thyroid-stimulating hormone), and arranging services to which both items 61426 and 66650 apply,


for the detection of recurrent well-differentiated thyroid cancer in a patient who:


(a)    has had a total thyroidectomy and one ablative dose of radioactive iodine; and

(b)    is maintained on thyroid hormone therapy; and

(c)    is at risk of recurrence; and

(d)        on at least one previous whole body scan or serum thyroglobulin test when withdrawn from thyroid hormone therapy did not have evidence of well differentiated thyroid cancer; and


    (i)    withdrawal from thyroid hormone therapy resulted in severe psychiatric disturbances when hypothyroid; or

    (ii)    withdrawal is medically contraindicated because the patient has:

        -    unstable coronary artery disease; or

        -    hypopituitarism ; or

        -    a high risk of relapse or exacerbation of a previous severe psychiatric illness


payable once only in any twelve month period.



Fee: $2,392.90 Benefit: 75% = $1,794.70 85% = $2,313.40

(See para D1.17 of explanatory notes to this Category)

Results 1 to 1 of 1 matches


Legend

  • Assist - Addition/Deletion of (Assist.)
  • Amend - Amended Description
  • Anaes - Anaesthetic Values Amended
  • Emsn - EMSN Change
  • Fee - Fee Amended
  • Renum - Item Number Change (renumbered)
  • New - New Item
  • NewMin - New Item (previous Ministerial Determination)
  • Qfe - QFE Change